NCT01756937

Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

A Six-month, Multi Center, Randomizied, Double Blind, Parallel-group,Placebo Controlled Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 287 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

Efficacy and safety of Imotun capsule in osteoarthritis of the knee

Detailed description

A six-month, multi center, randomizied, double blind, parallel-group,placebo controlled study to evaluate efficacy and safety of Imotun capsule in osteoarthritis of the knee

Conditions

• Osteoarthritis of the Knee

Interventions

Type	Name	Description
DRUG	Imotun	300.03mg/cap,orally, 1 capsule once daily for 24 weeks
DRUG	Placebo	1 capsule once daily for 24 weeks

Timeline

• Start date: 2013-01-01
• Primary completion: 2016-10-01
• Completion: 2017-02-01
• First posted: 2012-12-28
• Last updated: 2017-03-27

Locations

9 sites across 1 country: South Korea